JP2022515480A5 - - Google Patents
Info
- Publication number
- JP2022515480A5 JP2022515480A5 JP2021537716A JP2021537716A JP2022515480A5 JP 2022515480 A5 JP2022515480 A5 JP 2022515480A5 JP 2021537716 A JP2021537716 A JP 2021537716A JP 2021537716 A JP2021537716 A JP 2021537716A JP 2022515480 A5 JP2022515480 A5 JP 2022515480A5
- Authority
- JP
- Japan
- Prior art keywords
- week
- ppp
- seq
- weeks
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862785316P | 2018-12-27 | 2018-12-27 | |
| US62/785,316 | 2018-12-27 | ||
| US201962815431P | 2019-03-08 | 2019-03-08 | |
| US62/815,431 | 2019-03-08 | ||
| US201962891464P | 2019-08-26 | 2019-08-26 | |
| US62/891,464 | 2019-08-26 | ||
| PCT/EP2019/086521 WO2020136101A1 (en) | 2018-12-27 | 2019-12-20 | Anti-il-36r antibodies for treatment of palmoplantar pustulosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022515480A JP2022515480A (ja) | 2022-02-18 |
| JP2022515480A5 true JP2022515480A5 (enExample) | 2022-12-21 |
Family
ID=69190739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537716A Pending JP2022515480A (ja) | 2018-12-27 | 2019-12-20 | 掌蹠膿疱症の処置のための抗ｉｌ－３６ｒ抗体 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20200207862A1 (enExample) |
| EP (1) | EP3902604A1 (enExample) |
| JP (1) | JP2022515480A (enExample) |
| KR (1) | KR20210119407A (enExample) |
| CN (1) | CN113301955A (enExample) |
| AU (1) | AU2019416727A1 (enExample) |
| BR (1) | BR112021010789A2 (enExample) |
| CA (2) | CA3265173A1 (enExample) |
| CL (1) | CL2021001685A1 (enExample) |
| IL (1) | IL284259A (enExample) |
| MX (1) | MX2021007807A (enExample) |
| PH (1) | PH12021551540A1 (enExample) |
| TW (1) | TW202037604A (enExample) |
| WO (1) | WO2020136101A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10526410B2 (en) | 2015-04-15 | 2020-01-07 | Anaptysbio, Inc. | Antibodies directed against interleukin 36 receptor (IL-36R) |
| AU2019236105B2 (en) | 2018-03-14 | 2025-07-31 | Boehringer Ingelheim International Gmbh | Use of anti-IL-36R antibodies for treatment of generalized pustular psoriasis |
| US11730812B2 (en) | 2019-03-08 | 2023-08-22 | Boehringer Ingelheim International Gmbh | Anti-IL-36R antibody formulations |
| MX2023000763A (es) * | 2020-07-17 | 2023-02-13 | Boehringer Ingelheim Int | Anticuerpos anti-il-36r para el tratamiento de dermatosis neutrofilas. |
| AU2021353854A1 (en) * | 2020-09-30 | 2023-05-04 | Boehringer Ingelheim International Gmbh | Anti-il-36r antibodies for treatment of chronic inflammatory pain |
| CN112094349B (zh) * | 2020-11-04 | 2021-02-09 | 上海华奥泰生物药业股份有限公司 | 靶向于白介素36r的抗体及其制备方法和应用 |
| BR112023014103A2 (pt) * | 2021-03-04 | 2023-10-10 | Boehringer Ingelheim Int | Métodos para o tratamento de gpp |
| EP4305207A2 (en) | 2021-03-12 | 2024-01-17 | Boehringer Ingelheim International GmbH | Biomarkers associated with anti-il-36r antibody treatment in generalized pustular psoriasis |
| MX2023012903A (es) * | 2021-05-03 | 2023-11-08 | Boehringer Ingelheim Int | Metodo para producir spesolimab. |
| EP4337257A1 (en) * | 2021-05-12 | 2024-03-20 | AnaptysBio, Inc. | Antibody composition |
| WO2023285362A1 (en) * | 2021-07-12 | 2023-01-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of il-36 inhibitors for the treatment of netherton syndrome |
| EP4638492A2 (en) * | 2022-12-23 | 2025-10-29 | Icosavax, Inc. | Antibodies against metapneumovirus fusion (f) protein and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| WO2009040602A1 (en) | 2007-09-25 | 2009-04-02 | Becton Dickinson France | Autoinject0r with deactivating means moveable by a safety shield |
| SI2780373T1 (sl) | 2011-11-16 | 2019-12-31 | Boehringer Ingelheim International Gmbh | Protitelesa proti IL-36R |
| CH705992A2 (de) | 2012-10-11 | 2013-06-14 | Tecpharma Licensing Ag | Injektionsvorrichtung. |
| US10526410B2 (en) * | 2015-04-15 | 2020-01-07 | Anaptysbio, Inc. | Antibodies directed against interleukin 36 receptor (IL-36R) |
| US11690956B2 (en) | 2015-04-24 | 2023-07-04 | Shl Medical Ag | Sub-assembly of a medicament delivery device and a medicament delivery device |
| CH711066A2 (de) | 2015-05-13 | 2016-11-15 | Tecpharma Licensing Ag | Verbesserte Injektionsvorrichtung. |
| JP6654773B2 (ja) * | 2015-12-25 | 2020-02-26 | 国立大学法人名古屋大学 | インターロイキン３６受容体アンタゴニスト欠損症の治療薬 |
| AU2019236105B2 (en) * | 2018-03-14 | 2025-07-31 | Boehringer Ingelheim International Gmbh | Use of anti-IL-36R antibodies for treatment of generalized pustular psoriasis |
-
2019
- 2019-12-20 KR KR1020217023769A patent/KR20210119407A/ko not_active Withdrawn
- 2019-12-20 MX MX2021007807A patent/MX2021007807A/es unknown
- 2019-12-20 US US16/722,133 patent/US20200207862A1/en not_active Abandoned
- 2019-12-20 CA CA3265173A patent/CA3265173A1/en active Pending
- 2019-12-20 BR BR112021010789-4A patent/BR112021010789A2/pt not_active Application Discontinuation
- 2019-12-20 CA CA3124996A patent/CA3124996A1/en active Pending
- 2019-12-20 TW TW108147070A patent/TW202037604A/zh unknown
- 2019-12-20 JP JP2021537716A patent/JP2022515480A/ja active Pending
- 2019-12-20 AU AU2019416727A patent/AU2019416727A1/en not_active Abandoned
- 2019-12-20 WO PCT/EP2019/086521 patent/WO2020136101A1/en not_active Ceased
- 2019-12-20 CN CN201980087043.9A patent/CN113301955A/zh active Pending
- 2019-12-20 EP EP19842584.5A patent/EP3902604A1/en active Pending
-
2021
- 2021-06-21 IL IL284259A patent/IL284259A/en unknown
- 2021-06-23 CL CL2021001685A patent/CL2021001685A1/es unknown
- 2021-06-26 PH PH12021551540A patent/PH12021551540A1/en unknown
-
2022
- 2022-08-10 US US17/818,723 patent/US20230131364A1/en not_active Abandoned
- 2022-11-10 US US18/054,303 patent/US20230115617A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11214621B2 (en) | Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist | |
| CN105517570B (zh) | 通过施用il-4r拮抗剂治疗鼻息肉症的方法 | |
| JP2022126773A (ja) | 難治性全身型重症筋無力症の処置のための方法 | |
| US12616749B2 (en) | Methods for treatment of psoriasis with an anti-oxLDL antibody | |
| US20220220211A1 (en) | Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist | |
| US20240209074A1 (en) | Methods of treating allergy using anti-bet v 1 antibodies | |
| US20240287170A1 (en) | Methods for treating systemic sclerosis | |
| US8012478B2 (en) | Use of anti-IL-20 antibody for treating stroke | |
| JP2021532176A5 (enExample) | ||
| WO2023215443A1 (en) | Compositions and methods for the treatment of neuromyelitis optica spectrum disorder | |
| JP2022529266A (ja) | 乾癬性関節炎に罹患している対象者の治療方法 | |
| JP7821160B2 (ja) | 造血幹細胞移植関連血栓性微小血管症（ｈｓｃｔ－ｔｍａ）を処置するための抗ｃ５抗体の用量及び投与 | |
| WO2019087133A1 (en) | Method of treating tendinopathy using interleukin-17 (il-17) | |
| US20250263471A1 (en) | Methods of treating allergy using anti-bet v 1 antibodies | |
| JP2023504209A (ja) | 視神経脊髄炎スペクトラム障害の治療のための抗ｃ５抗体 | |
| CA3257386A1 (en) | METHOD FOR TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17) ANTAGONISTS | |
| CN115531531A (zh) | 抗人vegf抗体和化疗联用在制备治疗结直肠癌药物中的用途 | |
| CN121843958A (zh) | 既往接受生物制剂治疗斑块状银屑病的受试者转用抗IL23p19抗体治疗斑块状银屑病的方法 | |
| WO2004087915A1 (ja) | Ｓｅｂ改変体およびそれを含有する免疫異常性疾患の予防・治療用剤 | |
| EA049619B1 (ru) | Способы лечения аллергии с применением антител к bet v 1 | |
| WO2026078117A1 (en) | Anti-il-5 antibody in the treatment of chronic rhinosinusitis with nasal polyps | |
| HK40052952B (en) | Compositions and methods for treatment of psoriasis | |
| HK40052952A (en) | Compositions and methods for treatment of psoriasis |